Log in to save to my catalogue

Towards a TDP-43-Based Biomarker for ALS and FTLD

Towards a TDP-43-Based Biomarker for ALS and FTLD

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6132775

Towards a TDP-43-Based Biomarker for ALS and FTLD

About this item

Full title

Towards a TDP-43-Based Biomarker for ALS and FTLD

Publisher

New York: Springer US

Journal title

Molecular neurobiology, 2018-10, Vol.55 (10), p.7789-7801

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

TDP-43 accumulates in nerve cells of nearly all cases of amyotrophic lateral sclerosis (ALS; the commonest form of motor neuron disease) and in the majority of Tau-negative frontotemporal lobar degeneration (FTLD). There is currently no biochemical test or marker of disease activity for ALS or FTLD, and the clinical diagnosis depends on the opinion...

Alternative Titles

Full title

Towards a TDP-43-Based Biomarker for ALS and FTLD

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6132775

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6132775

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-018-0947-6

How to access this item